237 related articles for article (PubMed ID: 31448094)
1. Converging physiological roles of the anthrax toxin receptors.
Sergeeva OA; van der Goot FG
F1000Res; 2019; 8():. PubMed ID: 31448094
[TBL] [Abstract][Full Text] [Related]
2. The dark sides of capillary morphogenesis gene 2.
Deuquet J; Lausch E; Superti-Furga A; van der Goot FG
EMBO J; 2012 Jan; 31(1):3-13. PubMed ID: 22215446
[TBL] [Abstract][Full Text] [Related]
3. Mutations in ANTXR1 cause GAPO syndrome.
Stránecký V; Hoischen A; Hartmannová H; Zaki MS; Chaudhary A; Zudaire E; Nosková L; Barešová V; Přistoupilová A; Hodaňová K; Sovová J; Hůlková H; Piherová L; Hehir-Kwa JY; de Silva D; Senanayake MP; Farrag S; Zeman J; Martásek P; Baxová A; Afifi HH; St Croix B; Brunner HG; Temtamy S; Kmoch S
Am J Hum Genet; 2013 May; 92(5):792-9. PubMed ID: 23602711
[TBL] [Abstract][Full Text] [Related]
4. Capillary morphogenesis protein-2 is the major receptor mediating lethality of anthrax toxin in vivo.
Liu S; Crown D; Miller-Randolph S; Moayeri M; Wang H; Hu H; Morley T; Leppla SH
Proc Natl Acad Sci U S A; 2009 Jul; 106(30):12424-9. PubMed ID: 19617532
[TBL] [Abstract][Full Text] [Related]
5. Regulatory mechanisms of anthrax toxin receptor 1-dependent vascular and connective tissue homeostasis.
Besschetnova TY; Ichimura T; Katebi N; St Croix B; Bonventre JV; Olsen BR
Matrix Biol; 2015 Mar; 42():56-73. PubMed ID: 25572963
[TBL] [Abstract][Full Text] [Related]
6. GAPO syndrome in seven new patients: Identification of five novel ANTXR1 mutations including the first large intragenic deletion.
Abdel-Hamid MS; Ismail S; Zaki MS; Abdel-Salam GMH; Otaify GA; Issa MY; Abdel-Kader M; Girgis M; Aboul-Ezz E; Mazen I; Aglan MS; Temtamy SA
Am J Med Genet A; 2019 Feb; 179(2):237-242. PubMed ID: 30575274
[TBL] [Abstract][Full Text] [Related]
7. The receptors that mediate the direct lethality of anthrax toxin.
Liu S; Zhang Y; Hoover B; Leppla SH
Toxins (Basel); 2012 Dec; 5(1):1-8. PubMed ID: 23271637
[TBL] [Abstract][Full Text] [Related]
8. Changing facial features in a child with GAPO syndrome caused by novel mutation in the ANTXR1 gene and uniparental disomy of chromosome 2.
Smigiel R; Rozensztrauch A; Walczak A; Rydzanicz M; Stawinski P; Berghausen-Mazur M; Kostrzewa G; Sasiadek M; Ploski R
Clin Dysmorphol; 2019 Oct; 28(4):211-214. PubMed ID: 31425299
[No Abstract] [Full Text] [Related]
9. GAPO syndrome with deafness: new feature or incidental finding?
Aggarwal S; Uttarilli A; Dalal AB
Clin Dysmorphol; 2013 Oct; 22(4):161-163. PubMed ID: 24326960
[No Abstract] [Full Text] [Related]
10. Whole exome sequencing identifies three novel mutations in ANTXR1 in families with GAPO syndrome.
Bayram Y; Pehlivan D; Karaca E; Gambin T; Jhangiani SN; Erdin S; Gonzaga-Jauregui C; Wiszniewski W; Muzny D; ; Elcioglu NH; Yildirim MS; Bozkurt B; Zamani AG; Boerwinkle E; Gibbs RA; Lupski JR
Am J Med Genet A; 2014 Sep; 164A(9):2328-34. PubMed ID: 25045128
[TBL] [Abstract][Full Text] [Related]
11. Anthrax Toxin Protective Antigen Variants That Selectively Utilize either the CMG2 or TEM8 Receptors for Cellular Uptake and Tumor Targeting.
Chen KH; Liu S; Leysath CE; Miller-Randolph S; Zhang Y; Fattah R; Bugge TH; Leppla SH
J Biol Chem; 2016 Oct; 291(42):22021-22029. PubMed ID: 27555325
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the interaction between anthrax toxin and its cellular receptors.
Liu S; Leung HJ; Leppla SH
Cell Microbiol; 2007 Apr; 9(4):977-87. PubMed ID: 17381430
[TBL] [Abstract][Full Text] [Related]
13. A novel mutation at ANTXR1 in an Indian patient with growth retardation-alopecia-pseudoanodontia-optic atrophy syndrome.
Chattopadhyay E; Ghose S; Ray A; Anjum N; Mazumdar A; Roy B
Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Nov; 124(5):e261-e265. PubMed ID: 28870703
[TBL] [Abstract][Full Text] [Related]
14. ANTXR1 deficiency promotes fibroblast senescence: implications for GAPO syndrome as a progeroid disorder.
Przyklenk M; Karmacharya S; Bonasera D; Pasanen-Zentz AL; Kmoch S; Paulsson M; Wagener R; Liccardi G; Schiavinato A
Sci Rep; 2024 Apr; 14(1):9321. PubMed ID: 38653789
[TBL] [Abstract][Full Text] [Related]
15. Selection of anthrax toxin protective antigen variants that discriminate between the cellular receptors TEM8 and CMG2 and achieve targeting of tumor cells.
Chen KH; Liu S; Bankston LA; Liddington RC; Leppla SH
J Biol Chem; 2007 Mar; 282(13):9834-9845. PubMed ID: 17251181
[TBL] [Abstract][Full Text] [Related]
16. Capillary morphogenesis gene 2 (CMG2) mediates growth factor-induced angiogenesis by regulating endothelial cell chemotaxis.
Cryan LM; Tsang TM; Stiles J; Bazinet L; Lee SL; Garrard S; Madrian E; Roberts C; Payne J; Jensen A; Frankel AE; Ackroyd PC; Christensen KA; Rogers MS
Angiogenesis; 2022 Aug; 25(3):397-410. PubMed ID: 35212873
[TBL] [Abstract][Full Text] [Related]
17. Targeted silencing of anthrax toxin receptors protects against anthrax toxins.
Arévalo MT; Navarro A; Arico CD; Li J; Alkhatib O; Chen S; Diaz-Arévalo D; Zeng M
J Biol Chem; 2014 May; 289(22):15730-8. PubMed ID: 24742682
[TBL] [Abstract][Full Text] [Related]
18. Differential dependence on N-glycosylation of anthrax toxin receptors CMG2 and TEM8.
Friebe S; Deuquet J; van der Goot FG
PLoS One; 2015; 10(3):e0119864. PubMed ID: 25781883
[TBL] [Abstract][Full Text] [Related]
19. Ligand Binding to the Collagen VI Receptor Triggers a Talin-to-RhoA Switch that Regulates Receptor Endocytosis.
Bürgi J; Abrami L; Castanon I; Abriata LA; Kunz B; Yan SE; Lera M; Unger S; Superti-Furga A; Peraro MD; Gaitan MG; van der Goot FG
Dev Cell; 2020 May; 53(4):418-430.e4. PubMed ID: 32428455
[TBL] [Abstract][Full Text] [Related]
20. Mutations in capillary morphogenesis gene-2 result in the allelic disorders juvenile hyaline fibromatosis and infantile systemic hyalinosis.
Dowling O; Difeo A; Ramirez MC; Tukel T; Narla G; Bonafe L; Kayserili H; Yuksel-Apak M; Paller AS; Norton K; Teebi AS; Grum-Tokars V; Martin GS; Davis GE; Glucksman MJ; Martignetti JA
Am J Hum Genet; 2003 Oct; 73(4):957-66. PubMed ID: 12973667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
